Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

Taipei Veterans General Hospital, VGHTPE, Taipei

IRCCS Istituti Fisioterapici Ospitalieri, Roma

Chang Gung Memorial Hospital LinKou, Taoyuan District

Calvary Mater Newcastle, Waratah

John Flynn Private Hospital, Tugun

The Queen Elizabeth Hospital, Woodville

Hospital Universitario Vall d'Hebron, Barcelona

NYU Laura and Isaac Perimutter Cancer Center, New York

Columbia University Medical Center, New York

Memorial Sloan Kettering Cancer Center, New York

Fondazione IRCC Istituto Nazionale dei Tumori, Milan

Hospital General Universitario, Madrid

Hospital Universitario Quiron Pozuelo, Madrid

Hospital Regional de Málaga, Málaga

Mayo Clinic, Jacksonville

Orlando Health, Inc, Orlando

Chungnam National University Hospital, Daejeon

Veneto Oncology Institute, Padua

Norton Cancer Center, Louisville

Kyungpook National University Chilgok Hospital, Daegu

Hospital Universitario Miguel Servet, Zaragoza

Azienda Ospedaliera Universitaria Senese Policlinico Le Scotte, Siena

Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari, Bari

UT Southwestern Medical Center of Dallas, Dallas

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

The Angeles Clinic and Research Institute, Los Angeles

UC San Diego Moores Cancer Center, La Jolla

Massachusetts General Hospital, Boston

Princess Margaret Cancer Centre, Toronto

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal

McGill University Health Center (MUHC), Montreal

Ospedale S. Maria della Misericordia, Perugia

The Catholic Univ. of Korea, Seoul St. Marys Hospital, Seoul

Severance Hospital Yonsei University Health System, Seoul

Samsung Medical Center, Gangam-gu

Seoul National University Hospital, Jongno-gu

Asan Medical Center, Songpa-Gu

Hospital Clinic Barcelona, Barcelona

Royal Marsden Hospital, London

The Christie Hospital, Manchester

The Churchill Hospital, Oxford